23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ME | GERN | LGND | ||
Company | 23Andme Holding Co. | Geron Corp | Ligand Pharm | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.74 | 3.30 | 69.45 | ||
High | 2.80 | 3.38 | 72.49 | ||
Low | 2.64 | 3.21 | 69.45 | ||
Last | 2.69 | 3.22 | 71.45 | ||
Change | -0.06 | -0.12 | +1.40 | ||
% Change | -2.18% | -3.59% | +2.00% | ||
Volume | 2,344,400 | 4,665,500 | 152,600 | ||
20-Day Average Volume | 1,991,810 | 9,616,640 | 105,980 | ||
Previous Close | 2.75 | 3.34 | 70.05 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.41 | 3.21 | 70.30 | ||
20-Day Raw Stochastic | 85.90% | 75.49% | 46.35% | ||
20-Day Relative Strength | 55.53% | 58.11% | 52.08% | ||
Weighted Alpha | -41.00 | +160.30 | -35.60 | ||
Today's Opinion | 56% Sell | 100% Buy | 40% Sell | ||
Previous Opinion | 64% Sell | 100% Buy | 40% Sell | ||
Last Month's Opinion | 88% Sell | 72% Buy | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +7.17% since 01/27/23 | -3.59% since 01/27/23 | +1.65% since 01/27/23 | ||
Low | 2.38 on 01/30/23 | 3.16 on 01/30/23 | 68.05 on 01/30/23 | ||
High | 2.80 on 02/03/23 | 3.42 on 02/02/23 | 72.49 on 02/03/23 | ||
1-Month | |||||
%Chg | +28.10% since 01/03/23 | +34.17% since 01/03/23 | +8.21% since 01/03/23 | ||
Low | 2.02 on 01/06/23 | 2.34 on 01/05/23 | 64.75 on 01/05/23 | ||
High | 2.80 on 02/03/23 | 3.84 on 01/04/23 | 78.00 on 01/26/23 | ||
3-Month | |||||
%Chg | -10.03% since 11/03/22 | +58.62% since 11/03/22 | +13.76% since 11/03/22 | ||
Low | 2.02 on 01/06/23 | 1.96 on 11/04/22 | 60.12 on 11/04/22 | ||
High | 3.50 on 11/11/22 | 3.84 on 01/04/23 | 83.95 on 11/14/22 | ||
6-Month | |||||
%Chg | -18.73% since 08/03/22 | +57.84% since 08/03/22 | -24.58% since 08/03/22 | ||
Low | 2.02 on 01/06/23 | 1.96 on 11/04/22 | 57.77 on 11/02/22 | ||
High | 6.31 on 08/11/22 | 3.84 on 01/04/23 | 109.00 on 08/15/22 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,225,255 | 1,227,577 | 1,207,076 | ||
Shares Outstanding, K | 455,485 | 381,235 | 16,894 | ||
Annual Sales | 271,890,000 | 1,390,000 | 277,130,000 | ||
Annual Net Income | -217,490,000 | -116,110,000 | 57,140,000 | ||
Last Quarter Sales | 75,660,000 | 300,000 | 66,090,000 | ||
Last Quarter Net Income | -66,070,000 | -41,050,000 | 400,000 | ||
60-Month Beta | 1.46 | 0.77 | 1.07 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.15 on 11/07/22 | -0.10 on 11/03/22 | 0.41 on 11/07/22 | ||
Latest Earnings Date | 02/08/23 | 03/09/23 | 02/16/23 | ||
Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 60.91 |